MediSieve
PrivateLast Round
Early Funding
Jun 23, 2021
Total Funding Raised
$9.71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MediSieve operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Early Funding round in June 2021.
MediSieve is a biotech company that has developed a magnetic blood filtration platform to remove specific harmful substances from a patient's bloodstream.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MediSieve Comparables
Compare MediSieve with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemotune AG | 89% | |
| ExThera Medical | 84% | |
| Immunicom, Inc. | 80% |
For institutional investors. Book with your work email.
MediSieve Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 23, 2021 | ||||
| Grant | Dec 30, 2020 | ||||
| Grant | Jun 11, 2020 | ||||
| Grant | Jan 30, 2019 | ||||
| Early Funding | Jun 4, 2018 | ||||
Grant | Feb 12, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MediSieve Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| London Business School | Grant |
| Rosetrees Trust | Grant |
| UKRI Innovate UK | Grant |
| Innovate UK | Grant |
| Funding London | Early Funding |
| National Institute for Health and Care Research | Grant |
| Biotechnology and Biological Sciences Research Council | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 8, 89% of headcount.
- Feb 2, 2026
Monthly visitors increased 907% MoM.
For institutional investors. Book with your work email.
MediSieve Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MediSieve's valuation, stock price, and market status.
Is MediSieve a public or private company?
MediSieve is a private company.
What is the current stock price of MediSieve?
MediSieve is a private company, so its shares have no public market price. Caplight tracks MediSieve's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MediSieve worth (valuation)?
Valuation information for MediSieve is not publicly available.
Can I buy MediSieve stock?
MediSieve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MediSieve's last funding round?
MediSieve's most recent funding round was Early Funding on June 23, 2021.
Who are the main investors in MediSieve?
Key investors in MediSieve include London Business School, Rosetrees Trust, UKRI Innovate UK, Innovate UK, Funding London.
Will MediSieve IPO soon?
No public IPO plans have been announced for MediSieve.
How can I track MediSieve secondary market activity?
Caplight tracks bids, offers, and trades in MediSieve's shares on secondary markets.